申请人:——
公开号:US20040247581A1
公开(公告)日:2004-12-09
The present invention describes a pharmaceutical, veterinary or alimentary composition comprising one or more bacterial strains capable of lowering the concentration of intestinal pathogenic peptides by means of peptidases of probiotic strains. The invention also relates to the use of such compositions, and a method for selection of probiotic strains. Also, the invention relates to novel bacterial strains.
本发明描述了一种药物、兽药或食品组合物,其中包含一种或多种细菌菌株,能够通过益生菌菌株的肽酶降低肠道致病肽的浓度。本发明还涉及此类组合物的用途,以及选择益生菌株的方法。此外,本发明还涉及新型细菌菌株。